Cargando…
CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388261/ https://www.ncbi.nlm.nih.gov/pubmed/37021536 http://dx.doi.org/10.3324/haematol.2022.282587 |
_version_ | 1785082074575667200 |
---|---|
author | Cavo, Michele |
author_facet | Cavo, Michele |
author_sort | Cavo, Michele |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10388261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-103882612023-08-01 CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma Cavo, Michele Haematologica Editorial Fondazione Ferrata Storti 2023-04-06 /pmc/articles/PMC10388261/ /pubmed/37021536 http://dx.doi.org/10.3324/haematol.2022.282587 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Editorial Cavo, Michele CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title | CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title_full | CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title_fullStr | CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title_full_unstemmed | CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title_short | CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
title_sort | car t-cell therapy for triple-class exposed relapsed/refractory multiple myeloma |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388261/ https://www.ncbi.nlm.nih.gov/pubmed/37021536 http://dx.doi.org/10.3324/haematol.2022.282587 |
work_keys_str_mv | AT cavomichele cartcelltherapyfortripleclassexposedrelapsedrefractorymultiplemyeloma |